Lack of association between interleukin-1 alpha, beta polymorphisms and Parkinson's disease

Neuroscience Letters

Volumn 480, Issue 2, 2010, Pages 158-161

  Liu, Guo Jun ^a   Feng, Ren Nan ^b   Luo, Chao ^b,c   Bi, Sheng ^a  

^a THE FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

^c CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Genetics; Interleukin; Meta analysis; Parkinson's disease; Polymorphism

Indexed keywords

INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA;

ARTICLE; DISEASE ASSOCIATION; GENETIC ASSOCIATION; GENOTYPE; HUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; RISK;

GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-1ALPHA; INTERLEUKIN-1BETA; PARKINSON DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK;

EID: 77954534871     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.06.032     Document Type: Article

References (20)

1. Blum-Degen D., Muller T., Kuhn W., Gerlach M., Przuntek H., Riederer P. Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients. Neurosci. Lett. 1995, 202:17-20.
2. Dodel R.C., Lohmuller F., Du Y., Eastwood B., Gocke P., Oertel W.H., Gasser T. A polymorphism in the intronic region of the IL-1alpha gene and the risk for Parkinson's disease. Neurology 2001, 56:982-983.
3. Driver J.A., Logroscino G., Gaziano J.M., Kurth T. Incidence and remaining lifetime risk of Parkinson disease in advanced age. Neurology 2009, 72:432-438.
4. Ghione I., Di Fonzo A., Saladino F., Del Bo R., Bresolin N., Comi G.P., Rango M. Parkin polymorphisms and environmental exposure: decrease in age at onset of Parkinson's disease. Neurotoxicology 2007, 28:698-701.
5. Hayes A., Green E.K., Pritchard A., Harris J.M., Zhang Y., Lambert J.C., Chartier-Harlin M.C., Pickering-Brown S.M., Lendon C.L., Mann D.M. A polymorphic variation in the interleukin 1A gene increases brain microglial cell activity in Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 2004, 75:1475-1477.
6. Hollegaard M.V., Bidwell J.L. Cytokine gene polymorphism in human disease: on-line databases. Genes Immun. 2006, 7(Suppl. 3):269-276.
7. Hu G., Antikainen R., Jousilahti P., Kivipelto M., Tuomilehto J. Total cholesterol and the risk of Parkinson disease. Neurology 2008, 70:1972-1979.
8. Infante J., Garcia-Gorostiaga I., Sanchez-Juan P., Sanchez-Quintana C., Gurpegui J.L., Rodriguez-Rodriguez E., Mateo I., Berciano J., Combarros O. Inflammation-related genes and the risk of Parkinson's disease: a multilocus approach. Eur. J. Neurol. 2008, 15:431-433.
9. Ishihara L., Brayne C. A systematic review of nutritional risk factors of Parkinson's disease. Nutr. Res. Rev. 2005, 18:259-282.
10. Mattila K.M., Rinne J.O., Lehtimaki T., Roytta M., Ahonen J.P., Hurme M. Association of an interleukin 1B gene polymorphism (-511) with Parkinson's disease in Finnish patients. J. Med. Genet. 2002, 39:400-402.
11. McGeer P.L., Yasojima K., McGeer E.G. Association of interleukin-1 beta polymorphisms with idiopathic Parkinson's disease. Neurosci. Lett. 2002, 326:67-69.
12. Mogi M., Harada M., Narabayashi H., Inagaki H., Minami M., Nagatsu T. Interleukin (IL)-1 beta, IL-2, IL-4, IL-6 and transforming growth factor-alpha levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson's disease. Neurosci. Lett. 1996, 211:13-16.
13. Moller J.C., Depboylu C., Kolsch H., Lohmuller F., Bandmann O., Gocke P., Du Y., Paus S., Wullner U., Gasser T., Oertel W.H., Klockgether T., Dodel R.C. Lack of association between the interleukin-1 alpha (-889) polymorphism and early-onset Parkinson's disease. Neurosci. Lett. 2004, 359:195-197.
14. Nishimura M., Kuno S., Kaji R., Yasuno K., Kawakami H. Glutathione-S-transferase-1 and interleukin-1beta gene polymorphisms in Japanese patients with Parkinson's disease. Mov. Disord. 2005, 20:901-902.
15. Nishimura M., Mizuta I., Mizuta E., Yamasaki S., Ohta M., Kuno S. Influence of interleukin-1beta gene polymorphisms on age-at-onset of sporadic Parkinson's disease. Neurosci. Lett. 2000, 284:73-76.
16. Ross O.A., O'Neill C., Rea I.M., Lynch T., Gosal D., Wallace A., Curran M.D., Middleton D., Gibson J.M. Functional promoter region polymorphism of the proinflammatory chemokine IL-8 gene associates with Parkinson's disease in the Irish. Hum. Immunol. 2004, 65:340-346.
17. Schulte T., Schols L., Muller T., Woitalla D., Berger K., Kruger R. Polymorphisms in the interleukin-1 alpha and beta genes and the risk for Parkinson's disease. Neurosci. Lett. 2002, 326:70-72.
18. Wahner A.D., Sinsheimer J.S., Bronstein J.M., Ritz B. Inflammatory cytokine gene polymorphisms and increased risk of Parkinson disease. Arch. Neurol. 2007, 64:836-840.
19. Wu Y.R., Chen C.M., Hwang J.C., Chen S.T., Feng I.H., Hsu H.C., Liu C.N., Liu Y.T., Lai Y.Y., Huang H.J., Lee-Chen G.J. Interleukin-1 alpha polymorphism has influence on late-onset sporadic Parkinson's disease in Taiwan. J. Neural Transm. 2007, 114:1173-1177.
20. Zhou Y.T., Yang J.F., Zhang Y.L., Wang X.Y., Chan P. Protective role of interlekin-1 alpha gene polymorphism in Chinese Han population with sporadic Parkinson's disease. Neurosci. Lett. 2008, 445:23-25.